Expanded Facilities and Capabilities at Insight Center in California
YMC America has invested in enhancing our West Coast capabilities with an upgraded Insight Center laboratory in Thousand Oaks, California!
This expansion means more space, more cutting-edge chromatography equipment, and even greater capacity to support our partners. Our dedicated team utilizes this advanced facility to provide key services, including:
- LC Method Development (HPLC/UHPLC) & Troubleshooting
- Complex Impurity Identification
- Column Screening, including No-Cost Chiral Screening
- Process Scale-Up & Scale-Down Separations for Purification
Whether you need method development, purity confirmation, or scaling support, our California lab is ready to deliver insights and solutions.
Previous Article
Shimadzu Visits YMC America Related Posts
September 21, 2026
Join us for our upcoming webinar titled Peptide Purification: From HPLC Origins to Process Intensification
This presentation explores the evolution of peptide purification, from the early days of reversed-phase HPLC to today’s large-scale manufacturing challenges. It covers practical strategies for preparative method development, stationary phase selection, and efficient scale-up, illustrated by a case study on tirzepatide purification. The session also introduces continuous chromatography using MCSGP technology and highlights its potential for process intensification in modern peptide manufacturing.
September 4, 2026
YMC America Brings U.S.-Supplied ASME U-Stamped DAC Columns to Pharmaceutical Manufacturers
YMC America will be the First U.S.-Based Supplier of ASME U-Stamped DAC Columns.
The company’s DAC columns support pharmaceutical and biopharmaceutical customers from process development through commercial production. Systems are used in laboratory, pilot, and production-scale chromatography applications, including purification processes for peptides, oligonucleotides, and small-molecule APIs.
September 10, 2026
Analytical Technologies for Therapeutic Peptides
Therapeutic peptides are an emerging class of active pharmaceutical ingredients that, together with other classes of bioproducts, have been attracting considerable attention due to their unique advantages. Their structure is based on well-defined amino acid sequences that may or may not contain structural modifications, resulting in molecules that generally range from 500 to 5000 Da. Currently, many examples can be used as medicines related to hormones, growth factors, neurotransmitters, among others.
